TechPoint accepting nominations for Mira technology awards
The awards are meant to showcase Indiana’s high-tech success stories and raise the profile of the tech community.
Life Science & Biotech
Articles
Dow Agro in legal skirmish over canola oil
Indianapolis-based Dow AgroSciences LLC has sued Cooper Industries Plc in an effort to clarify its rights to make a canola-based
fluid used in electrical transformers.
Entrepreneur says quality of venture capital as important as quantity
Jim Pearson knows a thing or two about raising money from venture capitalists. And he has some advice for BioCrossroads:
Teach entrepreneurs the value of money.
First Indiana Future Fund off to a slow start
More than half of the venture capital fund’s original investors took a pass on its $58 million successor, the newly launched
INext.
Senate rejects drug-importation proposal
The U.S. Senate voted down a plan Tuesday to allow Americans to import prescriptions from abroad, handing drug makers
such as Indianapolis-based Eli Lilly and Co. a victory.
New BioCrossroads venture fund raises $58 million
The new INext fund is the successor to the $73 million Indiana Future Fund, which the life science initiative raised in 2003.
Company’s medical device earns expedited review
FAST Diagnostics LLC said initial human trials on its method to measure kidney function faster and more accurately than existing
techniques could begin as early as next year, with commercialization following by 2012.
Ariad asks court to restore patent-suit win against Lilly
A federal appeals court will decide whether Eli Lilly and Co. must pay $65.2 million in damages, plus royalties, over a drug-patent
claim.
Builder looks to cold storage for steady work in a weak economy
Cold storage might become a hot business for a building contractor.
Downtown life sciences corridor flagged for development
A new task force is charged with making recommendations for development of the city’s downtown certified technology
park.
Zimmer offering seeks $1B
The Indiana-based orthopedic implant maker plans to use the proceeds to pay down debt and for general corporate purposes.
Aarden Pharmaceuticals chose Indianapolis over San Diego for headquarters
Thanks partly to a state grant and support from Indiana’s BioCrossroads life sciences initiative, principals “decided
locating here would give Aarden a better chance of success.
FDA questions role of payments in Zimmer study
Federal health officials say an implant from Indiana-based Zimmer Holdings Inc. appears to be effective in treating spinal
problems, but questions remain about whether company payments to doctors influenced the device’s trial data.
Indiana among 15 states accusing Amgen of illegal kickbacks
Biotechnology behemoth Amgen Inc. is being sued by 15 states, including Indiana, alleging the company gave kickbacks to medical
providers to help boost sales of the Aranesp.
Lilly opens new biotech center in San Diego
Lilly is opening the San Diego biotech center a year after launching a biotech R&D center in Indianapolis.
Pace of life sciences venture capital deals in Indiana picks up
After no Indiana health and life sciences firms announced venture capital deals in the second quarter, five did so in the
third, and two more have already this month.
TechPoint to focus on IT firms specializing in medical, life sciences sectors
Long tracking the emergence of information technology firms involved in the health and life sciences sector, the state’s
IT trade group, TechPoint, is undergoing a mitosis of sorts to help fuel the trend. It has created Advancing
Life Science & Health Care Information Technology, or ALHIT, which will focus on growing this subset of the IT realm.
Indianapolis-based FAST Diagnostics gets funding from BioCrossroads’ seed fund
Money will help the company refine its tool to treat acute kidney injury.
Dow AgroSciences’ revenue, profit fall on lower crop prices
Dow AgroSciences, the local subsidiary of Midland, Mich.-based Dow Chemical Co., said Thursday that revenue fell 20 percent
and profits plummeted in the third quarter due largely to lower crop commodity prices.
Zimmer profits fall, but beat expectations
The Warsaw-based company recorded a third-quarter profit of $150 million, down 30 percent from the same quarter a year ago.